Abstract:Background: Persistent kidney fibroblast activation and tubular epithelial cell (TEC) injury are key contributors to CKD. However, transcriptional and cellular identities of advanced kidney disease, along with renal fibroblast specific markers and molecular targets contributing to persistent tubular injury, remain elusive. Methods: We performed single-cell RNA sequencing with two clinically relevant murine kidney fibrosis models. Day 28 post-injury was chosen to ensure advanced fibrotic disease. Identified gene expression signatures were validated using multiple quantitative molecular analyses. Results: We revealed comprehensive single cell transcriptomic profiles of two independent kidney fibrosis models compared to normal control. Both models exhibited key CKD characteristics including renal blood flow decline, inflammatory expansion and proximal tubular loss. We identified novel populations including secretory, migratory and contractile activated fibroblasts, specifically labelled by newly identified fibroblast-specific Gucy1a3 expression. Fibrotic kidneys elicited elevated embryonic and pro-fibrotic signaling, including separate Embryonic and Pro-fibrotic TEC clusters. Also, fibrosis caused enhanced cell-to-cell crosstalk, particularly between activated fibroblasts and pro-fibrotic TECs. Analysis of factors mediating mesenchymal phenotype in the injured epithelium identified persistent elevation of Ahnak, previously reported in AKI, in both CKD models. AHNAK knockdown in primary human renal proximal tubular epithelial cells induced a pro-fibrotic phenotype and exacerbated TGFb response via p38, p42/44, pAKT, BMP and MMP signaling. Conclusions: Our study comprehensively examined kidney fibrosis in two independent models at the singe-cell resolution, providing a valuable resource for the field. Moreover, we newly identified Gucy1a3 as a kidney activated fibroblast specific marker and validated AHNAK as a putative disease target.

Epidermal growth factor receptor activation is essential for kidney fibrosis development

EGFR signaling in renal fibrosis.

Selective Activation of Epidermal Growth Factor Receptor in Renal Proximal Tubule Induces Tubulointerstitial Fibrosis.

Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.

Epidermal Growth Factor Receptor Signaling Mediates Aldosterone-Induced Profibrotic Responses in Kidney.

Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury.

Dysregulated Mesenchymal PDGFR‐β Drives Kidney Fibrosis

EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis

Role Of Receptor Tyrosine Kinase Signaling In Renal Fibrosis

D-glucuronyl C5-epimerase binds to EGFR to suppress kidney fibrosis

Single-cell transcriptomic profiling of kidney fibrosis identifies a novel specific fibroblast marker and putative disease target

Cell-cell communication in kidney fibrosis

Renal Fibrosis and Epithelial-Mesenchymal Transition

Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases

Upregulation of HER2 in tubular epithelial cell drives fibroblast activation and renal fibrosis

Kidney Fibrosis: from Mechanisms to Therapeutic Medicines

Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis

Renal fibrosis: New insights into the pathogenesis and therapeutics

Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis

Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease

Role of epidermal growth factor receptor in acute and chronic kidney injury.